ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,740.16
1.35%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. NeuroOne Medical Technologies Corporation (NMTC)

  7. NeuroOne Medical Technologies Corporation (NMTC) 뉴스

NMTC NeuroOne Medical Technologies Corporation

1.1899
-0.0201 (-1.66%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
NeuroOne Medical Technologies Corporation NMTC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.0201 -1.66% 1.1899 08:19:56
개장가 저가 고가 종가 전일 종가
1.23 1.15 1.231 1.17 1.21
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/04/202422:00GLOBENeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
09/04/202422:05GLOBENeuroOne® Announces First Implant of OneRF™ Ablation..
04/04/202422:00GLOBENeuroOne® CEO Dave Rosa Featured on Fox Business Network’s..
26/03/202422:00GLOBENeuroOne® Initiates Limited Commercial Launch of OneRF™..
09/03/202402:00GLOBENeuroOne® to Participate in the 36th Annual Roth Conference
05/03/202404:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202404:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202403:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202407:10GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
22/02/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:15EDGAR2Form 8-K - Current report
14/02/202406:00GLOBENeuroOne® Reports First Quarter Fiscal Year 2024 Financial..
09/02/202405:30GLOBENeuroOne® to Report First Quarter Fiscal Year 2024 Financial..
02/02/202403:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/01/202423:02EDGAR2Form ARS - Annual Report to Security Holders
29/01/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
06/01/202406:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/01/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202306:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202323:35EDGAR2Form 144 - Report of proposed sale of securities
16/12/202306:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/12/202306:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/12/202306:30EDGAR2Form 8-K - Current report
15/12/202306:15GLOBENeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year..
11/12/202322:15EDGAR2Form 8-K - Current report
11/12/202322:00GLOBENeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™..
08/12/202306:30GLOBENeuroOne® to Report Fourth Quarter and Fiscal Year 2023..
05/12/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202306:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202322:00EDGAR2Form 8-K - Current report
16/11/202322:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
15/11/202307:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
14/11/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:15EDGAR2Form 8-K - Current report
07/11/202322:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..

최근 히스토리

NASDAQ
NMTC
NeuroOne Medical Technol...
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유